文献速递肝胆胰外科围术期管理与 ERAS

胰腺剜除术患者长期生活质量与普通人群相当:倾向性评分匹配分析

Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity Score-Matched Analysis.
PubMed 文献 · Ann Surg · 2021-04-14

该回顾性研究纳入2010至2019年连续接受胰腺剜除术(PE)的患者,评估围术期结局及长期生活质量(QoL),并与倾向性评分匹配的普通人群健康对照比较。结果显示PE术后Clavien-Dindo≥3级并发症率为16.0%,新发糖尿病(NODM)率7.1%,中位随访74.2个月时除EORTC-Pan26量表中「对未来担忧」和「体象」两项外,QoL各维度与普通人群相当。

要点

  • PE术后严重并发症(Clavien-Dindo≥3级)率为16.0%,但住院死亡率为0%。
  • 术后中位随访74.2个月,新发糖尿病率仅7.1%,年龄为独立预测因素。
  • 长期QoL与匹配的普通人群相当,仅「对未来担忧」和「体象」两项存在差异。

核心结论

  • 尽管胰腺剜除术伴随显著的术后并发症,但其长期结局优异,新发糖尿病风险低且与年龄相关。
  • 胰腺剜除术后患者长期生活质量与普通人群相当,仅「对未来担忧」和「体象」两项症状评分存在差异。
  • 上述信息应支持外科医生在适应证明确时选择胰腺剜除术。

研究设计与样本

  • 采用EORTC-C30和EORTC-Pan26问卷进行横断面生活质量评估,并与倾向性评分匹配的普通人群健康对照比较。

主要发现

  • 手术并发症率和Clavien-Dindo≥3级并发症率分别为48.1%和16.0%,住院死亡率为0%。
  • 术后胰瘘、胰切除后出血和胃排空延迟发生率分别为21.0%、9.9%和4.9%。
  • 问卷在中位术后74.2个月返回;术后新发糖尿病见于5例(7.1%),年龄为独立预测因素;7例(10.0%)出现术后外分泌功能不全。
  • 生活质量分析中,除EORTC-Pan26量表的「对未来担忧」和「体象」两项症状评分外(P < 0.05),两组所有功能与症状量表均具有可比性。

关键数值与推荐

  • 胰腺剜除术后Clavien-Dindo≥3级并发症率为16.0%,住院死亡率为0%。
  • 术后胰瘘、胰切除后出血和胃排空延迟发生率分别为21.0%、9.9%和4.9%。
  • 术后新发糖尿病率为7.1%(5例),年龄为独立预测因素;术后外分泌功能不全率为10.0%(7例)。
  • 中位随访74.2个月时,EORTC-C30和EORTC-Pan26多数量表评分与匹配的普通人群无显著差异,仅「对未来担忧」和「体象」两项差异有统计学意义(P < 0.05)。

临床怎么用

  • 在适应证明确时,胰腺剜除术可作为保留胰腺内外分泌功能的选择,长期生活质量与普通人群相当。
  • 术前应结合患者年龄评估新发糖尿病风险,术后需关注外分泌功能不全及「对未来担忧」「体象」等生活质量维度。
  • 尽管严重并发症率约16.0%,但住院死亡率为0%,围术期管理应聚焦于胰瘘、出血和胃排空延迟的防治。

局限性

  • 生活质量为横断面评估,缺乏术前基线数据,无法推断PE对生活质量的纵向影响。
  • 对照人群来自普通健康个体,虽经倾向性评分匹配,仍可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess short- and long-term outcomes including quality of life (QoL) following pancreatic enucleation (PE). BACKGROUND: PE is deemed to preserve both the endocrine and the exocrine function while ensuring radicality. However, to assess whether this reflects an actual benefit perceived by patients, QoL has to be considered. METHODS: Data from all consecutive patients undergoing PE from January 2010 to December 2019 were retrospectively analyzed. Surgical outcomes were graded according to the Clavien-Dindo classification, and EORTC-C30 and the EORTC-Pan26 were administered as a cross-sectional assessment of QoL. A control group consisting of healthy individuals from the general population was obtained and matched using the propensity score matching method. RESULTS: Eighty-one patients underwent PE using the open (59.3%), laparoscopic (27.2%), or robot-assisted (13.5%) approach. Sixty-five (80.2%) patients exhibited functioning/nonfunctioning pancreatic neuroendocrine tumors at final pathology.Surgical morbidity and complications of a Clavien-Dindo grade ≥3 were 48.1% and 16.0%, respectively. In-hospital mortality was 0%. Postoperative pancreatic fistula, post-pancreatectomy hemorrhage, and delayed gastric emptying rates were 21.0%, 9.9%, and 4.9%, respectively.Patients returned the questionnaires after a median of 74.2 months from the index surgery. Postoperative new onset of diabetes mellitus (NODM) was observed in 5 subjects (7.1%), with age being an independent predictor. Seven patients (10.0%) developed postoperative exocrine insufficiency. At the analysis of QoL, all function and symptom scales were comparable between the 2 groups, except for 2 of the EORTC-Pan 26 symptom scales, ("worries for the future" and "body image", P < 0.05). CONCLUSIONS: Despite being associated with significant postoperative morbidity, PE provides excellent long-term outcomes. The risk of NODM is low and related to patient age, with QoL being comparable to the general population. Such information should drive surgeons to pursue PE whenever properly indicated.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Giuliani T, De Pastena M, Paiella S, et al. Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity Score-Matched Analysis. Ann Surg. 2021. PMID: 33856383. doi:10.1097/SLA.0000000000004911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。